Conflicts of interest None declared.
Bleomycin and the skin
Article first published online: 10 AUG 2006
British Journal of Dermatology
Volume 155, Issue 5, pages 869–875, November 2006
How to Cite
Yamamoto, T. (2006), Bleomycin and the skin. British Journal of Dermatology, 155: 869–875. doi: 10.1111/j.1365-2133.2006.07474.x
- Issue published online: 10 AUG 2006
- Article first published online: 10 AUG 2006
- Accepted for publication 17 April 2006
- adverse effects;
Bleomycin is frequently used as a chemotherapeutic agent to treat various kinds of malignancy. However, the cytotoxic effects of bleomycin cause a number of adverse responses, in particular in the lung and the skin. Bleomycin is used by dermatologists as a treatment for various skin cancers, recalcitrant warts, keloid and hypertrophic scars. This article discusses the use of bleomycin for various skin disorders, as well as the risk factors and cutaneous side-effects resulting from its use.